New Long-Read Genetic Test Enables Faster and More Comprehensive Diagnosis of Rare Diseases
November 18, 2025
Brand Name :
Visine Maximum redness relief, Visine original, Visine Advanced Relief
Synonyms :
tetrahydrozoline, ophthalmic
Class :
Decongestant, Ophthalmic, Adrenergic Agonists
Brand Name :
Visine Maximum redness relief, Visine original, Visine Advanced Relief
Synonyms :
tetrahydrozoline, ophthalmic
Class :
Decongestant, Ophthalmic, Adrenergic Agonists
Dosage Forms & Strengths
Ophthalmic solution
0.05%
Indicated for Conjunctival Congestion:
Administer 1-2 drops into each affected eye every 6 to 12 hours. Do not exceed 72hours of usage
Safety and efficacy not established
Refer adult dosing
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may increase the risk or severity of hypertension when combined
may diminish the antihypertensive activity when combined
may diminish the antihypertensive activity when combined
may diminish the antihypertensive activity when combined
may diminish the antihypertensive activity when combined
may diminish the antihypertensive activity when combined
Mechanism of action
The mechanism of action of tetrahydrozoline ophthalmic involves the constriction of blood vessels in the eyes, reducing the flow of blood to the affected area. This leads to a reduction in the redness and swelling associated with allergic reactions or other irritants. The drug achieves this effect by binding to alpha-2 adrenergic receptors, which are present in the smooth muscle cells of blood vessels
Spectrum
The spectrum of activity of tetrahydrozoline ophthalmic is limited to the eyes and the surrounding tissues. It is ineffective in treating conditions that affect other body parts
Frequency  not defined:
Blurred vision
Tremor
Tachycardia
Burning/Irritation
Headache
Palpitation
Contraindications
Contraindications of tetrahydrozoline ophthalmic include:
Caution
While tetrahydrozoline ophthalmic is generally safe and well-tolerated when used as directed, some cautions should be taken into consideration when using this medication:
Pregnancy consideration: C
Lactation: Excretion of the drug in human breast milk is unknown
Pregnancy category:
Category A: well-controlled and Satisfactory studies show no risk to the fetus in the first or later trimester.
Category B: there was no evidence of risk to the fetus in animal studies, and there were not enough studies on pregnant women.
Category C: there was evidence of risk of adverse effects in animal reproduction studies, and no adequate evidence in human studies must take care of potential risks in pregnant women.
Category D: adequate data with sufficient evidence of human fetal risk from various platforms, but despite the potential risk, and used only in emergency cases for potential benefits.
Category X: Drugs listed in this category outweigh the risks over benefits. Hence these categories of drugs need to be avoided by pregnant women.
Category N: There is no data available for the drug under this category
Pharmacology
The pharmacology of tetrahydrozoline ophthalmic involves its action as a sympathomimetic drug, specifically an alpha-adrenergic agonist. Alpha-adrenergic receptors are found in various body tissues, including the eyes. When tetrahydrozoline is applied topically to the eyes, it binds to these receptors and causes them to constrict, reducing blood flow to the area
In addition to its vasoconstrictive effects, tetrahydrozoline ophthalmic also has some local anesthetic properties that can help to relieve eye irritation and discomfort
Pharmacodynamics
The pharmacodynamics of tetrahydrozoline ophthalmic involves its interaction with alpha-adrenergic receptors in the eyes. It is a selective alpha-1 adrenergic receptor agonist which binds to and activates alpha-1 receptors in the smooth muscle of the blood vessels in the eyes.
Activation of these receptors causes vasoconstriction or narrowing of the blood vessels, which results in decreased blood flow to the eyes. It reduces redness and swelling of the conjunctiva (the thin layer that covers the white part of the eye). This action also decreases the amount of fluid that leaks out of blood vessels, decreasing edema and irritation
In addition to its alpha-1 adrenergic effects, tetrahydrozoline ophthalmic also has some local anesthetic properties that can relieve eye discomfort and irritation
Pharmacokinetics
Absorption
When applied topically to the eye, tetrahydrozoline ophthalmic is absorbed through the conjunctiva and cornea into the aqueous humor and the bloodstream. The absorption of the medication into the systemic circulation is minimal.
Distribution
tetrahydrozoline ophthalmic has a relatively short half-life of about 2-3 hours and is primarily distributed to the ocular tissues after topical administration. The medication does not appear to accumulate in the body with repeated dosing
Metabolism
tetrahydrozoline ophthalmic is metabolized primarily by hepatic enzymes, specifically by the cytochrome P450 2D6 (CYP2D6) pathway. The major metabolite of tetrahydrozoline ophthalmic is 2-amino-1,2-dihydro naphthalene, which is excreted in the urine
Elimination and Excretion
The elimination of tetrahydrozoline ophthalmic occurs primarily through renal excretion of the metabolites. The medication and its metabolites are excreted rapidly, with up to 90% of the dose being eliminated within 24 hours of administration
Administration
Patient information leaflet
Generic Name: tetrahydrozoline, ophthalmic
Pronounced:[ TE-tra-hye-DROZ-oh-leen-off-THAL-mik ]
Why do we use tetrahydrozoline, ophthalmic?
tetrahydrozoline ophthalmic is a medication used to relieve eye redness caused by minor eye irritations, such as smoke, dust, wind, or pollen. It works by narrowing the blood vessels in the eye, which reduces redness and swelling
Here are some common uses of tetrahydrozoline ophthalmic: